250
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Ketamine versus Magnesium Sulphate as Adjuvants to Levobupivacaine in Ultrasound Bilevel Erector Spinae Block in Breast Cancer Surgery (a Double-Blinded Randomized Controlled Study)

ORCID Icon, , , , ORCID Icon & ORCID Icon
Pages 87-96 | Received 13 Jul 2022, Accepted 14 Sep 2022, Published online: 23 Sep 2022
 

Abstract

Purpose

Breast surgeons seek simple, safe, effective, and novel regional anesthesia techniques for postoperative analgesia. Erector spinae plane (ESP) block is a new ultrasound-guided technique. We aimed to explore the analgesic effect of adding ketamine and magnesium sulfate as adjuvants to levobupivacaine in ESP.

Patients and Methods

Sixty female patients (aged 18–60 years) with breast cancer, weighing 50–90 kg who were scheduled for modified radical mastectomy (MRM) were randomly allocated into three groups (20 patients each) to receive an ESP block with 20 mL 0.25% levobupivacaine with adjuvants according to the following groups: group C: levobupivacaine; group K: levobupivacaine + 2 mg/kg ketamine; and group M: levobupivacaine + 2 mg/kg magnesium sulfate. The block was administered preoperatively before anesthesia induction. Postoperatively, hemodynamics, visual analog scale scores, the first request for analgesia, total analgesic consumption, and side effects were observed for 48 hours.

Results

The total amount of Morphine rescue analgesia was significantly lower in groups M (7.00 ± 0.61 mg) and K (7.50 ± 0.58 mg) than in group C (14.40 ± 3.47 mg) during the first 48 h postoperatively. Nine (45%) patients in group M and 13 (65%) patients in K, compared with 20 (100%) patients in group C, requested analgesia. The time to first request of analgesia was significantly longer in groups M (30 h) and K (24 h) than in group C (7 h). No hemodynamic changes or serious side effects were observed.

Conclusion

Magnesium sulphate and ketamine seem to be both effective adjuvants to levobupivacaine in ESP blocks for postoperative analgesia in patients undergoing MRM, with slightly better analgesia provided by magnesium sulphate.

Data Sharing Information

Raw data (de-identified) used in this clinical trial are available from the corresponding author Dr Fatma Elsherif. It will be available following publication up on reasonable request and for a period of 2 years.

Implication Statement

This is a randomized controlled clinical trial comparing bilevel erector spinae block with ketamine versus magnesium sulphate added to levobupivacaine for postoperative analgesia in breast cancer surgery. This study conforms with Helsinki Declaration.

Acknowledgments

We are grateful to the operating theatre and SICU staff for their co-operation in data collection. This work was based on a thesis titled: “Efficacy and safety of ketamine versus magnesium sulphate as adjuvants to levobupivacaine in Ultrasound (US) bilevel erector spinae block in breast cancer surgery”. The study was obtained by the Institutional Medical Ethics Committee, Faculty of Medicine, Assiut University, on 15 June 2020 (IRB no. 17101099), and was recorded on the Egyptian Universities Libraries Consortium (http://www.eulc.edu.eg). It was prospectively registered at www.clinicaltrial.gov No. NCT04275661.

Disclosure

The authors declare no conflicts of interest in this work.